Clinical Trial Update: IV Ketamine vs. IN Esketamine for MDD TRD

View source ↗

Summary

A clinical trial comparing intravenous ketamine with intranasal esketamine for treatment-resistant depression is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Esketamine (esketamine)
• Ketamine (ketamine)

Snippet

Sponsor: Gustavo Vazquez | Conditions: Treatment Resistant Depression | Status: RECRUITING